Edwards Lifesciences Corporation (EW): Analyzing Basic Trading Data

In the past 52-week period, shares of Edwards Lifesciences Corporation (NYSE:EW) have moved within the range of $81.12 to $121.45. On the stock’s most recent trading day, the company’s shares ended the regular session at $116.41, which is 4.15% lower than its 52-week high.

Edwards Lifesciences Corporation (EW) has demonstrated a 20-day simple moving average (SMA) of 8.46%, and a 50-day SMA of 7.50%. This public company’s current market capitalization stands at $24.60 billion.

Analyzing Consensus Estimates, Sales Revenue and Net Income

Gauging the level of enthusiasm that Wall Street analysts have for a particular stock is important when considering an investment. According to the latest data, the consensus recommendation for Edwards Lifesciences Corporation (EW) is Outperform.

When it comes to reporting sales figures, public companies typically post earnings and revenue that fall above or below the average Wall Street forecast. In the most recent quarterly financial report, for the quarter ending Sep. 2017, Edwards Lifesciences Corporation (EW) delivered a 0.78% surprise with its net revenue. Sales reached $0.84 billion during the three-month period, compared to the average analyst estimate of $0.83 billion.

Meanwhile, during the same quarter Edwards Lifesciences Corporation (EW) delivered a 2.54% earnings surprise. Net earnings for the quarter were posted at $0.84 per share, whereas Wall Street had forecast $0.86 per share.

Ownership at Edwards Lifesciences Corporation (EW), According to Most Recent SEC Filings

A publicly-traded company’s most recent 13F filings give us important details about the organization’s institutional ownership. Edwards Lifesciences Corporation (EW) has 0 billion shares outstanding currently, 83.40% of which belong to institutional investors. Those institutional holdings amount to $20.55 billion.

Additionally, according to the most recent 13F filing from Edwards Lifesciences Corporation (EW), there were 83 new positions totaling 2,387,863 shares of the company’s stock. There were 56 sold out positions, on the other hand, totaling 1,576,198 shares.

Short, Medium and Long Term Indicators

Taking a look at a stock’s average volume – in the long, medium and short terms – is helpful for understanding investor sentiment and trading activity. Edwards Lifesciences Corporation (EW) has had a 20-day average volume of 1,412,085 shares, with an average of 40% of short term indicators pointed at Buy.

The stock’s 50-day average volume has been 1,570,584 shares, with an average of 50% of medium term indicators pointing toward Buy. Finally, its 100-day average volume is 1,436,434 shares with 33% of long-term indicators pointing to Buy.